Pulmatrix Inc

Research Pulmatrix Inc (PULM) on Bullrun: market cap USD 5.95M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPULM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.95M
• Financial periodFY2025
• Net income-USD 5.16M

Valuation Snapshot

latest market cap is USD 5.95M.

About Pulmatrix Inc

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Frequently asked questions

What is Pulmatrix Inc's market cap?

Pulmatrix Inc's market capitalization is USD 5.95M.

What does Pulmatrix Inc do?

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States.